A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of repeated doses of
GS-9411 in healthy volunteers. GS-9411 is a sodium channel inhibitor, that may restore airway
hydration and mucociliary clearance in the lung.